Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTOG 9811: Mitomycin vs Cisplatin in Anal Cancer
NCT00003596Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Oct 1998
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cisplatin in anal cancer, sponsored by NRG Oncology. Started Oct 1998; status: completed.
02
Drugs
cisplatin
03
Conditions
anal cancer
Beyond the preview
Go deeper on NCT00003596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003596.